ITRM910710A0 - METHOD FOR THE DETERMINATION OF TUMOR NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM - Google Patents

METHOD FOR THE DETERMINATION OF TUMOR NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM

Info

Publication number
ITRM910710A0
ITRM910710A0 IT91RM710A ITRM910710A ITRM910710A0 IT RM910710 A0 ITRM910710 A0 IT RM910710A0 IT 91RM710 A IT91RM710 A IT 91RM710A IT RM910710 A ITRM910710 A IT RM910710A IT RM910710 A0 ITRM910710 A0 IT RM910710A0
Authority
IT
Italy
Prior art keywords
tnf
determination
biologically active
necrosis factor
tumor necrosis
Prior art date
Application number
IT91RM710A
Other languages
Italian (it)
Inventor
Angelo Corti
Original Assignee
Tecnogen Scpa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnogen Scpa filed Critical Tecnogen Scpa
Priority to ITRM910710A priority Critical patent/IT1249708B/en
Publication of ITRM910710A0 publication Critical patent/ITRM910710A0/en
Priority to JP5505949A priority patent/JPH07502113A/en
Priority to AU26905/92A priority patent/AU2690592A/en
Priority to EP92921308A priority patent/EP0605635A1/en
Priority to PCT/IT1992/000116 priority patent/WO1993006489A1/en
Publication of ITRM910710A1 publication Critical patent/ITRM910710A1/en
Application granted granted Critical
Publication of IT1249708B publication Critical patent/IT1249708B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ITRM910710A 1991-09-23 1991-09-23 METHOD FOR DETERMINING THE TUMORAL NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM. IT1249708B (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITRM910710A IT1249708B (en) 1991-09-23 1991-09-23 METHOD FOR DETERMINING THE TUMORAL NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM.
JP5505949A JPH07502113A (en) 1991-09-23 1992-09-17 Method for detecting bioactive tumor necrosis factor (TNF)
AU26905/92A AU2690592A (en) 1991-09-23 1992-09-17 Method to detect tumor necrosis factor (tnf) as bioactive form
EP92921308A EP0605635A1 (en) 1991-09-23 1992-09-17 Method to detect tumor necrosis factor (tnf) as bioactive form
PCT/IT1992/000116 WO1993006489A1 (en) 1991-09-23 1992-09-17 Method to detect tumor necrosis factor (tnf) as bioactive form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910710A IT1249708B (en) 1991-09-23 1991-09-23 METHOD FOR DETERMINING THE TUMORAL NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM.

Publications (3)

Publication Number Publication Date
ITRM910710A0 true ITRM910710A0 (en) 1991-09-23
ITRM910710A1 ITRM910710A1 (en) 1993-03-23
IT1249708B IT1249708B (en) 1995-03-09

Family

ID=11400369

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910710A IT1249708B (en) 1991-09-23 1991-09-23 METHOD FOR DETERMINING THE TUMORAL NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM.

Country Status (5)

Country Link
EP (1) EP0605635A1 (en)
JP (1) JPH07502113A (en)
AU (1) AU2690592A (en)
IT (1) IT1249708B (en)
WO (1) WO1993006489A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112409B2 (en) 1999-01-29 2006-09-26 Center For Molecular Medicine And Immunology Method of determining cytokine dosage for myelosuppressive state
US6649352B1 (en) * 1999-01-29 2003-11-18 Center For Molecular Medicine And Immunology Method of evaluating myelosuppressive state
GB201510758D0 (en) 2015-06-18 2015-08-05 Ucb Biopharma Sprl Novel TNFa structure for use in therapy
GB201621907D0 (en) 2016-12-21 2017-02-01 Ucb Biopharma Sprl And Sanofi Antibody epitope

Also Published As

Publication number Publication date
JPH07502113A (en) 1995-03-02
IT1249708B (en) 1995-03-09
EP0605635A1 (en) 1994-07-13
ITRM910710A1 (en) 1993-03-23
WO1993006489A1 (en) 1993-04-01
AU2690592A (en) 1993-04-27

Similar Documents

Publication Publication Date Title
FI941459A (en) Tumor necrosis factor muteins
DK0542795T5 (en) TNF inhibitors
ITMI910519A0 (en) INTEGRATED PROCEDURE FOR THE PRODUCTION OF ISO-BUTENE AND ALKYL-TER-BUTYL ETHERS
FR2622202B1 (en) CEMENTING MATERIAL AND CEMENTING METHOD USING THE SAME
ITRM910710A0 (en) METHOD FOR THE DETERMINATION OF TUMOR NECROSIS FACTOR (TNF) IN BIOLOGICALLY ACTIVE FORM
KR930702896A (en) Tumor necrosis factor inhibitor
ITMI910774A0 (en) METHOD FOR THE PREPARATION OF INTERLEUKIN 6
AU9071291A (en) Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy
IL99705A0 (en) Inhibitors for the formation of tumor necrosis factor,processes for the preparation thereof and the use thereof
MX9200040A (en) GROWTH FACTOR OF THE RECOMBINANT BASIC HUMAN FIBROBLAST AND METHOD FOR OBTAINING IT.
IT1236340B (en) METHOD FOR THE CREATION OF CHANNELING PARTICULARLY IN THE FLOORS
IT8821667A0 (en) PROCEDURE FOR THE PREPARATION OF RECOMBINANT HUMAN INTERLEUKIN 1 BETA IN HOMOGENEOUS FORM.
IT215356Z2 (en) ADJUSTABLE FOOT FOR THE SUPPORT OF STRUCTURES IN GENERAL.
ITTV910066A0 (en) IMPROVED PROCEDURE PARTICULARLY FOR THE FORMATION OF CURVED LAMINATE PANELS
ITMI920778A1 (en) PROCEDURE FOR THE DISCONTINUOUS PREPARATION OF ALCHILARIL CARBONATES
IT9003389A0 (en) SET OF ELEMENTS FOR THE CREATION OF DECORATIVE GEOMETRIC STRUCTURES IN DOUBLE GLASS
ITMI910847U1 (en) STRUCTURE OF CANNUCCIA FOR SORBIRE BEVERAGES IN GENERAL
ITRM930001A0 (en) PROCEDURE FOR THE FURTHER ELECTROSTATIC PROCESSING OF RAW SALTS IN HIGH HUMIDITY.
ITPD920057V0 (en) EQUIPMENT FOR THE COLLECTION OF SMALL BODIES, IN PARTS-COLARE SYRINGES
IE882290L (en) Treatment of infections with tumor necrosis factor
IT9022498A0 (en) HEIGHT ADJUSTABLE FURNITURE FOOT
ITTV910012A1 (en) PROCEDURE PERFECTED FOR THE PARTICULAR REALIZATION OF ENCLOSED CHIPBOARD PANELS
IT1228675B (en) METHOD AND ELEMENTS FOR THE REALIZATION OF ARCHES AND ARTIFICIAL GALLERIES, IN PARTICULAR ABOVE ROADS.
IT8819547A0 (en) PROCEDURE FOR THE CREATION OF BRICK BLOCKS SO OBTAINED.
IT212192Z2 (en) COMPLEX OF ELEMENTS FOR THE CREATION OF SPACE STRUCTURES FOR FURNITURE

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960909